MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$6,336,000
+26.1%
379,152
+8.8%
0.00%0.0%
Q1 2020$5,026,000
-51.5%
348,519
+12.5%
0.00%
-50.0%
Q4 2019$10,371,000
-8.5%
309,860
-42.7%
0.00%
-20.0%
Q3 2019$11,333,000
+28.9%
541,217
+28.2%
0.01%
+25.0%
Q2 2019$8,790,000
-6.3%
422,209
+0.6%
0.00%0.0%
Q1 2019$9,380,000
-6.6%
419,702
-0.1%
0.00%
-20.0%
Q4 2018$10,046,000
+13.7%
419,974
+29.6%
0.01%
+25.0%
Q3 2018$8,838,000
+26.2%
323,981
+24.4%
0.00%
+33.3%
Q2 2018$7,003,000
-1.5%
260,435
+16.6%
0.00%0.0%
Q1 2018$7,110,000223,3820.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders